Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 7, 2009

Premium

Celera said this week that Joel Jung has resigned as chief financial officer to pursue other opportunities. Celera has appointed Ugo DeBlasi as its new CFO, effective immediately.

DeBlasi previously worked for Applera, holding several positions including chief accounting officer and vice president and controller. Prior to Applera, he worked as a senior auditor for Price Waterhouse.

DeBlasi holds a BS in accounting from Boston College and is a licensed certified public accountant.


Christopher Ahlberg has joined Fina Technologies' board of directors. Ahlberg, a founder and former CEO of Spotfire, also serves on the board of directors at Apptus Technologies AB and the Hult International Business School. He also was executive VP of Tibco and president of Tibco's Spotfire division.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more